APAC Anatomic Pathology Market Size & Growth (2019 - 2024)
The Anatomic Pathology Market in the Asia Pacific region is estimated to worth USD 2.92 billion in 2019 and is estimated to be growing at a CAGR of 7.92%, to reach USD 4.27 billion by 2024.
The market in this region is displaying obvious potential in the said determining period. Anatomy Pathology is the branch of medicine that deals with the diagnosis of diseases based on the various levels of examinations of organs and tissues.
Anatomy Pathology features the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. The data generated by Anatomy Pathology is further analyzed and is used by doctors for better health management. Anatomy Pathology is basically one of the branches of the pathology stream, other being the Clinical Pathology.
With the enormous number of ongoing developments and innovations in healthcare, rising spending capabilities and increasing awareness of the people in this region, there has also been a rise in the market. People have also become prone to more and more harmful diseases as time has changed because of increasing adaptability of micro-organisms against various medications. This market is facing challenges mainly competing with the Physician Groups, like specialty physicians merging or adding ancillary services and large commercial labs. There is a constant significant reimbursement pressure. Awareness is increasing in this region about diseases at a very fast rate, still, overall awareness of the people is very less. These factors may act as growth hurdles for the Anatomy Pathology Market in this region.
This report segmented and sub-segmented into the following categories:
By Product: Instruments and Accessories
By End-User: Diagnostics Lab, Hospitals, and Physicians’ Office Lab
By Application: Lymphoma, Breast, Lung, Cervical, Colorectal, and Prostate
By Country: China, Japan, India, South Korea, Australia and Rest of APAC
Regional Analysis:
The Asia Pacific is one of the most lucrative markets for the growth of the Anatomy Pathology market and is projected to grow the highest during the forecast period. Factors such as growing demographics and emerging economies in countries such as India and China are anticipated to lead the growth of the market in this region.
Promising companies in the market
The Asia Pacific Anatomic Pathology Market in this region is highly monopolized in this region. Some of the major companies dominating the market in this region are Sakura Fine technical Co., Ltd. (Japan), Metropolis (India) and IBISWorld’s Pathology Services (Australia).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.3 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 End-User
5.2.1 Introduction
5.2.2 Diagnostics Lab
5.2.3 Hospitals
5.2.4 Physicians' Office Lab
5.2.5 Y-o-Y Growth Analysis, By End-User
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By End-User
5.3 Application
5.3.1 Introduction
5.3.2 Lymphoma
5.3.3 Breast
5.3.4 Lung
5.3.5 Cervical
5.3.6 Colorectal
5.3.7 Prostate
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type End-User
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type End-User
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type End-User
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 F. Hoffmann-La Roche AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 NeoGenomics Laboratories Inc.
8.3 Laboratory Corporation of America Holdings
8.4 Thermo Fisher Scientific
8.5 Quest Diagnostics Incorporated
8.6 Agilent Technologies
8.7 Danaher Corporation
8.8 Sakura Finetechnical Co. Ltd.
8.9 Metropolis
8.10 IBISWorld’s Pathology Services
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures